TABLE 2.

Synthetic oligonucleotides used in this study

Oligonucleotide	Sequence
For nuclease S1 protection assays
virB1	5′-CCCCGATCTCTTAAACATACCTTATCTCCTTAGCTCGCCCTGG-3′
rpoD	5′-CCCTTCGCGCGACAGAAGCTCGACGGAACCCATTTCTATAC-3′
virD5	5′-GCCCTCAATACCAAATCTTTCCAAGTCGGTGGCTCCGCCTCGGCCCCTGA-3′
virE3	5′-GGGGCTCTCCAGTCTGGTTTGCCGCTTGAGCGCTCTCCT-3′
ORF12	5′-GGATTGCAAGCTCCACCCCCTGATCCTCGAGGTGAAGTAGGAAGGC-3′
ORF13	5′-CGGCGTCGACGGCATTCTCCGCATCGCGACGGTGGTAAATA-3′
ORF14	5′-CGGGACCTCCGTCGTCCGGCGTAATGCAACCAATTTGG-3′
ORF15	5′-GGGCTGCATCGCCGGATTGGTTCGCCGAAGGACCGGAACCCTTTT-3′
ORF16	5′-GCCGAGACTTCTTCCCATTGCCGTTTCAGGTCAAA-3′
ORF17	5′-GGCCGAGCGGCTCGCTTGGGGTCAGGTTCAGTTAGG-3′
virP	5′-GGATTGCAAGCTCCACCCCCTGATCCTCGAGGTGAAGTAGGAAGGC-3′
virR	5′-GCGCCACGGCCCACGGTTCCGAAATTTCAAGTGTGCATAGTGGCCCACCG-3′
For PCR amplification
virD5	5′-AGAATTCCCGGCCCACGTGGAAAGACC-3′
	5′-ATCTAGACGGCTCGCCTAAGGGAACACC-3′
virE3	5′-CCAGACTGGAGAGCCCCG-3′
	5′-CCATTTTCGTCGCGCTCCC-3′
ORF12-lacZ	5′-CCGAATTCGTTCCTCGTGACTTGCCCCC-3′
	5′-CGTCTAGAGACGGCGTCGACGGCATTCTC-3′
ORF16-lacZ	5′-GGGGTACCGCGCCGCCGTCTTCGTGTCCG-3′
	5′-GCTCTAGAAACCACGCCGCCGGAATCAGG-3′
virP-lacZ	5′-CGAATTCGATGGTACGTTGGCAGACAGTGGT-3′
	5′-CCTCTAGACTTATTAATCCTTTTGCCCTTCC-3′
virR-lacZ	5′-GGAATTCTGTCATGCACTCAACCAGATT-3′
	5′-GGTCTAGATCAGCGGGACTTAGTAGGACGATA-3′